Abstract
Since melatonin receptors are present in the intestines, the possibility that this hormone may affect intestinal motility has been studied in the rat. Sprague-Dawley male rats were given a carmine cochineal powder meal and were injected intraperitoneally with 1, 10, 100, or 1000 μg/kg melatonin. Sixty minutes after treatment, intestinal transit was found to be faster in animals treated with small doses of melatonin (1 or 10 μg/kg) than in saline-injected controls. This effect, however, appear to be clearly reversed with 100 or 1000 μg/kg melatonin. In fact, these doses of the hormone reduced intestinal transit in rats. The nonselective melatonin receptor antagonist, luzindole (administered intraperitoneally in a dose of 0.25 mg/kg, 15 min prior to melatonin injection) totally prevented the accelerating effect of melatonin (10 μg/kg) on intestinal transit. Luzindole per se failed to affect gut motility. Injection of the reversible acetylcholinesterase inhibitor and cholinergic agent, neostigmine, accelerated intestinal transit but failed to influence melatonin effect on this parameter. In contrast, intraperitoneal injection of the muscarinic receptor antagonist atropine delayed intestinal transit per se but did not reduce the stimulating effect of melatonin on this parameter. Intestinal myoelectrical recording revealed that intestinal myoelectrical activity was increased by intraperitoneal injection of melatonin (10 μg/kg). Administration of luzindole totally prevented melatonin-induced increase of intestinal myoelectrical activity. These results indicate that melatonin may affect intestinal motility in rats when administered in small doses. This effect might be mediated by melatonin receptors in the intestines, although the involvement of central receptors for the hormone is also possible.
Similar content being viewed by others
REFERENCES
Watson SJ, Maden J: Melatonin and other pineal substances: psychiatric and neurological implication. In Neuroregulators and Psychiatric Disorders. E Usdin, DA Hamburg, JD Barchas (eds). New York, Oxford University Press, 1977, pp 193–200
Lerner AB, Norlund JH: Melatonin: Clinical pharmacology. J Neural Transm 13:339–347, 1978
Relkin R: Pineal-hormonal interactions. In The Pineal Gland. R Relkin (ed), New York, Elsevier Biomedical, 1983, pp 225–231
Waldhauser F, Leberman HR, Linch HJ, Waldhauser M, Herkner K, Frish H: A pharmacological dose of melatonin increases PRL levels in males without altering those of GH, LH, FSH TSH, testosterone or cortisol. Neuroendocrinology 46:125–132, 1987
Cahill GM, Besharse JC: Circadian clock functions localized in xenopus retinal photoreceptors. Neuron 10:573–577, 1993
Argyriou A: Melatonin facilitates short-term memory. Eur J Pharmacol 349:159–163, 1998
Drago F, Busà L, Benelli A, Bertolini A: Acute low doses of melatonin stimulate rat sex behavior: The role of serotonin neurotransmission. Eur J Pharmacol 385:1–6, 1999
Bubenik GA, Blask DE, Brown GM, Maestroni GJ, Pang SF, Reiter RJ, Viswanathan M, Zisapel N: Prospects of the clinical utilization of melatonin. Biol Signals Recept 7:195–219, 1998
Dubocovich ML: Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 16:50–56, 1995
Reppert SM, Weaver DR, Ebisawa T: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13:1177–1185, 1994
Reiter RJ: Pineal melatonin: Cell biology of its synthesis and of its physiological interaction. Endocrinol Rev 12:151–159, 1991
Sugden D: Melatonin receptor pharmacology: toward subtype specificity. Biol Cell 89:531–537, 1998
Pontoire C, Bernard M, Silvain C, Collin JP, Voisin P: Characterization of melatonin binding sites in chicken and human intestines. Eur J Pharmacol 247:111–118, 1993
Lee PP, Pang SF: Melatonin and its receptors in the gastrointestinal tract. Biol Signals 2:181–193, 1993
Giusti P, Lipartiti M, Franceschini D, Schiavo N, Floreani M, Manev H: Neuroprotection by melatonin from kainateinduced exotitotoxicity in rats. FASEB J 10:891–896, 1996
Coon SL, Rosenboom PH, Baler R, Weller JL, Namboodiri MAA, Koonin EV, Klein DC: Pineal serotonin N-acetyltransferase: Expression cloning and molecular analysis. Science 270:1681–1683, 1995
Konturek PC, Konturek SJ, Brzozowski T, Dembinski A, Zembala M, Mytar B, Hahn EG: Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stress-induced and ischaemia-induced lesions is mediated by scavenge of oxygen radicals. Scand J Gastroenterol 32:433–438, 1997
Konturek PC, Konturek SJ, Majka J, Zembala M, Hahn EG: Melatonin affords protection against gastric lesions induced by ischemia–reperfusion possibly due to its antioxidant and mucosal microcirculatory effects. Eur J Pharmacol 322:73–77, 1997
Khan R, Burton S, Morley S, Daya S, Potgieter B: The effect of melatonin on the formation of gastric stress lesions in rats. Experientia 46:88–89, 1990
Alarcon de la Lastra C, Motilva V, Martin MJ, Nieto A, Barranco MD, Cabeza J, Herrerias JM: Protective effect of melatonin on indomethacin-induced gastric injury in rats. J Pineal Res 26:101–107, 1999
Kato K, Murai I, Asai S, Matsuno Y, Komuro S, Kaneda N, Iwasaki A, Ishikawa K, Nakagawa S, Arakawa Y, Kuwayama H: Protective role of melatonin and the pineal gland in modulating water immersion restraint stress ulcer in rats. J Clin Gastroenterol 27(suppl I):S110–S115, 1998
Melchiorri D, Sewerynek E, Reiter RJ, Ortiz GG, Poeggeler B, Nistico G: Suppressive effect of melatonin administration on ethanol-induced gastroduodenal injury in rats in vivo. Br J Pharmacol 121:264–270, 1977
Cho CH, Pang SF, Chen BW, Pfeiffer CJ: Modulating action of melatonin on serotonin-induced aggravation of ethanol ulceration and changes of mucosal blood flow in rat stomachs. J Pineal Res 6:89–97, 1989
Kato K, Murai I, Asai S, Komuro S, Matsuno Y, Matsukawa Y, Kurosaka H, Iwasaki A, Ishikawa K, Arakawa Y: Central effect of melatonin against stress-induced gastric ulcers in rats. Neuroreport 8:2305–2309, 1997
Kato K, Murai I, Asai S, Takahashi Y, Matsuno Y, Komuro S, Kurosaka H, Iwasaki A, Ishikawa K, Arakawa Y: Central nervous system action of melatonin on gastric acid and pepsin secretion in pylorus-ligated rats. Neuroreport 9:3989–3992, 1998
Bubenik GA, Hacker RR, Brown GM, Bartos L: Melatonin concentrations in the luminal fluid, mucosa, and muscularis of the bovine and porcine gastrointestinal tract. J Pineal Res J 26:56–63, 1999
Bubenik GA, Pang SF, Hacker RR, Smith PS: Melatonin concentrations in serum and tissues of porcine gastrointestinal tract and their relationship to the intake and passage of food. J Pineal Res 21:251–256, 1996
Bonouali-Pellissier S: Melatonin is involved in cholecystokinininduced changes of ileal motility in rats. J Pineal Res 17:79–85, 1994
Bonouali-Pellissier S: Colecystokinin effect on intestinal motility depends on the light–dark cycle in the rat: Actions of melatonin and its receptor antagonist S 20928. Brain–Gut 2000 Symposium, Toulouse, Abs. 56
Yamada K, Maruyama K, Mogami S, Miyagawa N, Tsuboi M: Influence of melatonin on reproductive behavior in male rats. Chem Pharm Bull (Tokyo) 40:2222–2223, 1992
Dubocovich ML: Luzindole (N-0774): A novel melatonin receptor antagonist. J Pharmacol Exp Ther 246:902–910, 1988
Dubocovich ML, Masana MI, Iacob S, Sauri DM: Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 355:365–375, 1997
Hansen MB, Skadhauge E: Signal transduction pathways for serotonin as an intestinal secretagogue. Comp Biochem Physiol 118:283–290, 1997
Miguez JM, Martin FJ, Aldegunde M: Melatonin effects on serotonin synthesis and metabolism in the striatum, nucleus accumbens, and dorsal and median raphe nuclei of rats. Neurochem Res 22:87–92, 1987
Hueter G, Messner M, Rodenbeck A, Hardeland R: Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J Pineal Res 24:146–151, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drago, F., Macauda, S. & Salehi, S. Small Doses of Melatonin Increase Intestinal Motility in Rats. Dig Dis Sci 47, 1969–1974 (2002). https://doi.org/10.1023/A:1019696006677
Issue Date:
DOI: https://doi.org/10.1023/A:1019696006677